Skip to main content
. 2018 Jul 31;7(15):e009351. doi: 10.1161/JAHA.118.009351

Table 4.

Accuracy and Coverage of the Algorithm Designed to Detect Pulse Irregularities Attributable to AF According to the ECV and HOL Testing Data Set

Testing Data Set Epoch‐by‐Epoch Statistics Episode Statistics Duration Statistics
Accuracy % (CI) Sensitivity % (CI) Specificity % (CI) NPV % (CI) PPV % (CI) Coverage % (CI) Sensitivity % (CI) PPV % (CI) Sensitivity % (CI) PPV % (CI)
ECV
Average 98±4 (96–100) 97±7 (91–100) 100±1 (99–100) 98±6 (93–100) 99±4 (96–100) 57±18 (46–68) 98±6 (94–100) 99±4 (96–100) 98±7 (93–100) 94±13 (86–99)
Gross 98 96 100 98 100 47 99 99 96 98
HOL
Average 97±10 (92–100) 93±14 (82–100) 100±0 (100–100) n.a. n.a. 52±12 (47–57) 95±11 (85–99) n.a. 93±14 (81–99) n.a.
Gross 97 93 100 95 100 48 95 100 93 100

Sensitivity and PPV for episode and duration statistics are defined according to the Association for the Advancement of Medical Instrumentation standards. AF indicates atrial fibrillation; CI, 95% confidence interval of the mean as obtained by bootstrapping and resampling of the test data set (100 iterations); ECV, cardioversion cohort of patients; Average, indicates accuracy described by mean (± SD deviation) of the value across patients; Gross, accuracy determined by aggregating results from each patient into one; HOL, Holter cohort of patients; NPV, negative predictive value; PPV, positive predictive value; n.a., not available. NPV and PPV could not be defined as average accuracy in epoch‐by‐epoch statistics because patients showed either AF or non‐AF in the reference annotations in the HOL cohort.